✦ LIBER ✦

Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non–Clear Cell Renal Cell Carcinoma

✍ Scribed by Oscar Rodríguez Faba; Alberto Breda; Antonio Rosales; Joan Palou; Ferran Algaba; Pablo Maroto Rey; Humberto Villavicencio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal cell carcinoma: evolving approache

✍ Daniel Y. C. Heng; Ronald M. Bukowski 📂 Article 📅 2007 🏛 PAGEPress Publications 🌐 English ⚖ 180 KB

Re: Sorafenib in Advanced Clear-Cell Ren

✍ Pierre I. Karakiewicz; Georg Hutterer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Cost-Effectiveness of Temsirolimus for F

✍ Martin Hoyle; Colin Green; Jo Thompson-Coon; Zulian Liu; Karen Welch; Tiffany Mo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Temsirolimus in patients with advanced r

✍ Shailender Bhatia; John A. Thompson 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 240 KB

Clinical Trial Experience With Temsiroli

✍ Gary R. Hudes; Anna Berkenblit; Jay Feingold; Michael B. Atkins; Brian I. Rini; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 634 KB

A Phase 2 Trial of Sunitinib in Patients

✍ Nizar M. Tannir; Elizabeth Plimack; Chaan Ng; Pheroze Tamboli; Nebiyou B. Bekele 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 180 KB